Mechanism action of Tobramycin
?Tobramycin, previously known as nebramycin factor 6, is an aminoglycoside aminocyclitol antibiotic, which is one of several compounds in an antibiotic complex (nebramycin) produced by Streptomyces te
Mar 11,2022 APIWhat is Gentamicin?
Gentamicin is a mixture of relatively equal amounts of three natural aminoglycosides, gentamicin C1, gentamicin C2, and gentamicin C1a, produced by Micromonospora purpurea and discovered in the Scheri
Mar 11,2022 APISide effects of Ciprofloxacin
Ciprofloxacin is a fluoroquinolone (also called 4-quinolone, or quinolone carboxylic acid) which was developed by Bayer Pharmaceuticals for both oral and parenteral use. It is one of the second genera
Mar 11,2022 APISide-effects of Nalidixic acid
Nalidixic acid (1-ethyl-l,4-dihydro-7-methyl-4-oxo-1, 8-naphthyridine- 3-carboxylic acid) is one of a series of 1,8-naphthyridine derivatives which were first synthesized by Lesher et al.from a distil
Mar 11,2022 Natural ProductsSide-effects of Tinidazole
Tinidazole, 1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole, is a nitroimidazole drug similar to metronidazole. It was synthesized in 1969 and it has a similar activity profile as metronidazole i
Mar 11,2022 APIPhenoxypenicillins: Antimicrobial Activity, Susceptibility, Administration and Dosage Clinical Uses etc.
Four acid-stable phenoxypenicillins have been developed, all suitable for oral administration. Their clinical use is restricted for the treatment of minor infections and chemoprophylaxis since the ser
Mar 11,2022 APIPreparation and use of vanillin
This article describes a background overview of vanillin and its preparation and application
Mar 11,2022 APIA kind of preparation method of dapagliflozin
This article describes a preparation method for dapagliflozin and an overview of its background
Mar 11,2022 APIA kind of preparation method and use of lactic acid
This article describes a preparation method and main uses of lactic acid
Mar 11,2022 APIClinical Uses of Penicillin G
Pen G remains a very effective treatment for infections caused by group A beta-hemolytic streptococci (which have not, to date, developed resistance to penicillin), such as pharyngitis, scarlet fever,
Mar 11,2022 API










